Characteristics of the study population according to tertiles of galectin-3BP level
| Characteristic | Tertile 1 (n=310) | Tertile 2 (n=311) | Tertile 3 (n=311) |
| Age (years), mean (SD) | 16.27 (1.04) | 16.27 (1.02) | 16.05 (0.91) |
| Girls, n (%) | 144 (46.45) | 148 (47.59) | 190 (61.09) |
| Anthropometry | |||
| BMI z-score, mean (SD) | 0.06 (1.17) | 0.43 (1.36) | 0.65 (1.36) |
| Waist circumference, mean (SD) | 71.95 (8.60) | 75.00 (11.54) | 75.97 (12.01) |
| Weight status, n (%) | |||
| NW | 250 (80.65) | 204 (65.59) | 181 (58.20) |
| OW | 40 (12.90) | 61 (19.61) | 73 (23.47) |
| OB | 20 (6.45) | 46 (14.79) | 57 (18.33) |
| MetS outcomes | |||
| MetS, n (%) | 8 (2.58) | 15 (4.82) | 23 (7.40) |
| Center obesity, n (%) | 48 (15.48) | 92 (29.58) | 106 (34.08) |
| Hypertension, n (%) | 69 (22.26) | 66 (21.22) | 82 (26.37) |
| Hyperglycemia, n (%) | 3 (0.97) | 5 (1.61) | 5 (1.61) |
| High_TG, n (%) | 26 (8.39) | 30 (9.65) | 26 (8.36) |
| Low_HDL-C, n (%) | 35 (11.29) | 43 (13.83) | 48 (15.43) |
| Laboratory examinations | |||
| FPG (mmol/L), median (Q1–Q3) | 4.28 (4.0–4.56) | 4.25 (3.96–4.53) | 4.31 (4.05–4.6) |
| TG (mmol/L), median (Q1–Q3) | 0.71 (0.53–0.98) | 0.76 (0.55–1.04) | 0.80 (0.59–1.07) |
| ALT (U/L), median (Q1–Q3) | 10 (8–16) | 10 (8–17) | 10 (8–17) |
| AST (U/L), median (Q1–Q3) | 15 (13–18) | 16 (13–19) | 15 (13–18) |
| ALP (U/L), median (Q1–Q3) | 96 (76–126) | 93 (77–117) | 93 (74–126) |
| GGT (U/L), median (Q1–Q3) | 16 (13–20) | 16 (13–22) | 16 (13–22) |
| C1q (mg/L), median (Q1–Q3) | 176.0 (156.6–201.4) | 177.6 (154.6–200.2) | 184.5 (167.5–209.5) |
| HDL-C (mmol/L), median (Q1–Q3) | 1.31 (1.14–1.50) | 1.30 (1.11–1.51) | 1.28 (1.13–1.51) |
| LDL-C (mmol/L), median (Q1–Q3) | 2.08 (1.70–2.50) | 2.12 (1.79–2.52) | 2.19 (1.80–2.58) |
| Apolipoprotein A1 (g/L), median (Q1–Q3) | 1.30 (1.21–1.42) | 1.31 (1.20–1.41) | 1.32 (1.19–1.45) |
| Apolipoprotein B (g/L), median (Q1–Q3) | 0.61 (0.52–0.72) | 0.63 (0.54–0.73) | 0.66 (0.56–0.76) |
| Small dense low-density lipoprotein cholesterol (mmol/L), median (Q1–Q3) | 0.42 (0.33–0.52) | 0.42 (0.33–0.51) | 0.43 (0.34–0.53) |
ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, Body Mass Index; FPG, fasting plasma glucose; galectin-3BP, galectin-3 binding protein; GGT, gamma-glutamyl transferase; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MetS, metabolic syndrome; NW, normal weight; OB, obesity; OW, overweight; TG, triglyceride.